Venkatesh R. Nathamuni
Management
Yes. Jamie, thanks for your question, and thanks for your comments as well about the quarter. I'd say, you know, lots of really positive trends for us from a margin perspective. You know, obviously, Q1, you know, we came in at 13.4%. And Q2, we're guiding for a 50 basis point sequential improvement. And then we see a linear progression in Q3 and Q4. So few things, you know, that drive that margin expansion for us. Number one, you know, continued operating leverage. So gonna maintain the discipline in terms of ensuring that our OpEx grows at a slower pace than revenue growth. And then, you know, clearly from the standpoint of some of the gross margin drivers that we talked about Investor Day, with the way we expect our global delivery to step up, which is already happening, and we see more of that coming in Q2, Q3, and Q4. And then also on the commercial model side. Right? So with the extent to the extent that we are engaging more with the life sciences and advanced manufacturing clients, that also helps, you know, from the standpoint of driving those commercial models. So I'd say it's not one thing. It's a combination of several things that we talked about in Investor Day, more of that coming to fruition in Q3 in Q2, Q3, and Q4, and we feel really good about our margin performance for the full year. Obviously, you know, just for context, you know, in fiscal 2025, we grew our margins by 110 basis points. And we're guiding for a range of 50 to 80 basis points increase in fiscal 2026.